hybrid photosensitive immunotherapy (IMAGE)
Caption
HKUMed pioneers the world’s first hybrid photosensitive immunotherapy for a breakthrough in cancer treatment.
Credit
The University of Hong Kong
Usage Restrictions
N/A
License
Original content